First needle less COVID vaccines for children and adult above 12 years got approval for EUA

Zydus Cadila’s ZyCov-D, Covid vaccine got Emergency Use Authorization for children and adults 12 years and above

The drug regulator of India approved Zydus Cadila’s three-dose COVID19 DNA vaccine for emergency use authorization for children 12 years and above. This is the second homegrown vaccine that has got approval against the deadly COVID19 infection. 

The company has applied for authorization of ZyCov-D on July 1st. It has an efficacy rate of 66.66 % in a late-stage trial of more than 28,000 volunteers nationwide. The company has developed vaccines in partnership with the Department of Biotechnology. ZyCoV-D is the world's first plasmid DNA vaccine against coronavirus. The company has planned to manufacture 100-120 million doses annually.

All about ZyCov-D

ZyCov-D is a three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus. ZyCov-D is effective against mutant strains of virus-like delta variants which are highly infectious. It will be administered on the 1st day – 28th day – 56th day. It elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance. It is an intradermal vaccine, applied using a ‘needle-free injector’. A needle-free system can lead to a significant reduction in side effects. The vaccine has been developed in partnership with the department under Mission COVID Suraksha.

It is the world's first and India's indigenously developed DNA-based vaccine for COVID-19 to be administered in humans including children and adults 12 years and above. Bharat Biotech’s Covaxin and ZydusCadila’s ZyCov-D are the only two vaccine candidates to have been tested among children in India and developed in India. 

Tags : #Spotlight #ZyCov-D #Covaxin #COVIDVaccine #Firstcovidvaccineforchildren12yearsandabove #NeedlelessCOVIDVaccine #ZydusCadila #Medicircle #SmitaKumar

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Dangers of Ultra-Processed Foods: A Wake-Up Call for Health Conscious IndiansMay 23, 2024
Can Intermittent Fasting Protect Against Liver Cancer? Here’s What the Science SaysMay 23, 2024
Easier, Faster Claims: The Impact of the National Claim Exchange PortalMay 23, 2024
Can Nightmares Predict Autoimmune Flares? Insights from a Groundbreaking StudyMay 23, 2024
Does Parent-Led Singing Improve Development in Preterm Infants? A Comprehensive StudyMay 22, 2024
Biohacking 101: Boosting Physical and Mental Well-beingMay 22, 2024
In a Miraculous Recovery a 13-Year-Old Girl in Delhi Awakens from Coma After Liver Transplant.May 21, 2024
Tackling Hypertension in South-East Asia: A Call to Action on World Hypertension DayMay 20, 2024
FSSAI's Crackdown on Harmful Fruit Ripening Practices: Ensuring Public Health and ComplianceMay 20, 2024
Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024